|
C2ORF86 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.79710000000255E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.74079999982047E-07 |
| Normal-vs-Stage2 |
2.309600E-02 |
| Normal-vs-Stage3 |
4.469600E-02 |
| Normal-vs-Stage4 |
7.215400E-01 |
| Stage1-vs-Stage2 |
6.681400E-01 |
| Stage1-vs-Stage3 |
5.611700E-02 |
| Stage1-vs-Stage4 |
2.478500E-03 |
| Stage2-vs-Stage3 |
3.665600E-01 |
| Stage2-vs-Stage4 |
6.161800E-02 |
| Stage3-vs-Stage4 |
2.045400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.36810000001186E-06 |
| Normal-vs-AfricanAmerican |
8.211000E-01 |
| Normal-vs-Asian |
1.658200E-01 |
| Caucasian-vs-AfricanAmerican |
2.741100E-03 |
| Caucasian-vs-Asian |
8.248400E-01 |
| AfricanAmerican-vs-Asian |
3.475200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.065000E-03 |
| Normal-vs-Female |
8.32729999955539E-07 |
| Male-vs-Female |
4.258600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.952600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.38870000000602E-05 |
| Normal-vs-Age(61-80Yrs) |
3.819600E-04 |
| Normal-vs-Age(81-100Yrs) |
5.260400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.368500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.347210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.974600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.099400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.533800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.440800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.560300E-03 |
| Normal-vs-Grade 2 |
2.39510000055176E-07 |
| Normal-vs-Grade 3 |
1.435670E-03 |
| Normal-vs-Grade 4 |
9.116500E-02 |
| Grade 1-vs-Grade 2 |
1.644990E-01 |
| Grade 1-vs-Grade 3 |
2.311800E-02 |
| Grade 1-vs-Grade 4 |
2.25819999999377E-05 |
| Grade 2-vs-Grade 3 |
5.386400E-02 |
| Grade 2-vs-Grade 4 |
4.2261000032795E-08 |
| Grade 3-vs-Grade 4 |
1.622710E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63602464908763E-12 |
| Normal-vs-ccB subtype |
4.700200E-01 |
| ccA subtype-vs-ccB subtype |
3.98020505443242E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.91450000003513E-06 |
| Normal-vs-N1 |
7.293000E-01 |
| N0-vs-N1 |
6.558000E-02 |
|
|
